|
|
|
|
|
by WiseWeasel
5108 days ago
|
|
Maybe the US is simply a poor market to launch new drugs into, if it costs that much to get it to market. It might be better to launch in other countries, like India, and then work towards a US launch after extensive use data is available. |
|